Search Results 411-420 of 31350 for Ovary
... Ovary Syndrome on the Basis of Ethnicity and Race? J Pediatr Adolesc Gynecol. 2024 Jun; 37 (3):348-352 Epub 2023 Dec 26. View PubMed; Loftus TJ, Ruppert MM ...
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Mayo Clinic. · Noninvasive detection of cancer. · Gynecologic cancer ...
Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer ... ovarian, primary ...
Ovarian cancer occurs at higher than expected rates in women with endometriosis, but the overall lifetime risk is low. Some studies suggest that endometriosis ...
Mesenchymal stem cells may be able to carry tumor-killing substances directly to ovarian cancer cells. Participation eligibility. Participant eligibility ...
This phase II trial studies how well olaparib and cediranib maleate work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that ...
Hope for ovarian cancer: New immunotherapy target featured image. Cancer. Hope for ovarian cancer: New immunotherapy target. Colette Gallagher. February 19 ...
Three cancers — ovarian epithelial cancer, fallopian tube cancer and primary peritoneal cancer — are commonly called[...] Latest stories. Teasing apart sex ...
According to the American Cancer Society, about 21,000 women will be diagnosed with ovarian cancer this year ... and more than 14,000 will die from the ...
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. Print details. Share ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.